Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus
Xin He,Jiping Sun,Chao Liu,Xiaoyang Yu,Huixian Li,Wenjing Zhang,Yan Li,Yingzhou Geng,Zhigang Wang
DOI: https://doi.org/10.2147/DMSO.S347805
2022-03-06
Abstract:Xin He, 1 Jiping Sun, 2 Chao Liu, 2 Xiaoyang Yu, 2 Huixian Li, 2 Wenjing Zhang, 2 Yan Li, 2 Yingzhou Geng, 2 Zhigang Wang 2 1 Dialysis Department of Nephrology Hospital, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, People's Republic of China; 2 Department of Nephrology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, People's Republic of China Correspondence: Zhigang Wang, First Affiliated Hospital of Xi'an Jiaotong University, West Yanta Road 277, Xi'an, 710061, People's Republic of China, Email Purpose: Emerging evidence has revealed that gut microbiota plays a pivotal role in the pathogenesis of type 2 diabetes mellitus (T 2 DM) and diabetic kidney disease (DKD). However, few studies have used metagenomic sequencing to analyze the alterations of gut microbiota community in patients with early-stage DKD. Methods: We carried out metagenomic sequencing in fecal samples of 10 DKD patients (DKD group) and 10 T 2 DM patients who appeared to be less prone to DKD (non-DKD group), aiming to compare the composition and function of gut microbiota between the DKD and non-DKD groups. Results: The gut microbial community of the DKD group was significantly different from that of the non-DKD group, characterized by a marked increase in phylum Proteobacteria, genus Selenomonadales, Neosynechococcus, Shigella, Bilophila, Acidaminococcus , species, Escherichia coli, Bacteroides plebeius, Megasphaera elsdenii, Acidaminococcus unclassified, and Bilophila wadsworthia . The amounts of species Citrobacter farmeri and Syntrophaceticus schinkii were significantly and positively correlated with the urinary albumin creatinine ratio in the DKD group. Furthermore, functional analysis based on dbCAN and KEGG databases showed aberrant lipopolysaccharide (LPS) biosynthesis and carbohydrate metabolism in the gut microbiome of the DKD group. Conclusion: Our findings provided evidence for alterations in the composition and function of gut microbiota in patients with DKD versus the non-DKD group. These data may contribute to a more comprehensive understanding of the pathological mechanisms of DKD. Keywords: diabetic kidney disease, gut microbiota, metagenomics, type 2 diabetes mellitus With the rapidly increasing world population and proportion of elderly, type 2 diabetes mellitus (T 2 DM), a well-known metabolic disease, has become a major global public health problem. 1 Diabetic kidney disease (DKD), characterized by proteinuria, hypertension, and progressive reductions in kidney function, is considered one of the most common diabetic complications and is the leading cause of end-stage renal disease (ESRD). 2 Besides the traditional risk factors such as high blood glucose level, high blood pressure, and altered lipid profiles, previous epidemiological studies have suggested the emerging role of genetic factors in DKD. It is estimated that only 30−40% of T 2 DM patients with long-term hyperglycemia ultimately develop DKD. 3 Also, DKD has been observed in some T 2 DM patients with good glycemic control, indicating that genetic susceptibility may play a critical role in the pathogenesis of DKD. 4 Gut microbiota is increasingly recognized to be associated with various metabolic diseases, such as obesity, 5 diabetes, 6 and cardiovascular diseases. 7 The human gastrointestinal tract harbors thousands of bacterial species, together comprising 10–100 trillion microbes, which encode approximately 150-fold more genes than the human genome. 8,9 The gut microbiota has been shown to modulate both local and systemic immunity and metabolism by inducing chronic inflammation and altering microbial metabolism and microenvironment. 10 Accumulating evidence has shown that changes in the composition and proportion of gut microbiota are closely related to an increased risk of developing T 2 DM and its associated complications. 11 Improvement of the gut microbiota alleviates the symptoms of diabetes, glucose tolerance, and insulin sensitivity in patients with T 2 DM. 12–14 The disturbance of the gut-kidney axis contributes to the pathogenesis of kidney disease through diverse mechanisms, including toxin secretion, epigenetic modification, 15 inflammation, 16 immune response, 17 mitochondrial dysfunction, 18 glycometabolism, 19 and short-chain fatty acids (SCFAs) metabolism, 20 all of which are key events during the progression of diabetes and DKD. -Abstract Truncated-